Phase II randomized, placebo-controlled trial of phytotherapeutic product Catuama for breast cancer women undergoing adjuvant radiation therapy.

医学 安慰剂 乳腺癌 医院焦虑抑郁量表 内科学 随机对照试验 生活质量(医疗保健) 癌症 不利影响 萧条(经济学) 外科 焦虑 精神科 病理 护理部 经济 替代医学 宏观经济学
作者
Felipe Melo Cruz,Daniel de Iracema Gomes Cubero,Patrícia Xavier Santi,Luciana Garcia Landeiro,Andressa Sayuri Tamashiro,Larisse Soares Ribeiro,Auro del Giglio
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology]
卷期号:31 (15_suppl): e20524-e20524
标识
DOI:10.1200/jco.2013.31.15_suppl.e20524
摘要

e20524 Background: Fatigue and Depression are common in patients undergoing Breast Cancer (BC) treatment. Catuama is a registered phytotherapic that contains 4 brazilian herbs per capsule: Trichilia catigua (87.5mg), Ptychopetalum olacoides (87.5mg), Paullinia cupana (125 mg) and Zingiber officinale (10mg). Objectives: Since one of its constituents is Guarana (Paulinia cupana) which we already reported to have anti-fatigue effects, we decided to test Catuama potential anti-fatigue effects in BC women undergoing adjuvant 4 weeks of Radiation Therapy (RxT). Methods: This is a double blinded, randomized, placebo-controlled, Phase II cross-over trial. Patients with histologically proven BC with the indication of adjuvant RxT, non-pregnant nor breastfeeding, older than 18 years of age, with ECOG PS 0 or 1, without a history of cardiac, renal, hepatic or psychiatric decompensation, received Catuama 1 capsule twice daily versus a matching placebo for the first 2 weeks of RxT treatment, followed by a week of wash out, followed by an additional two weeks of treatment with crossover of experimental arms. Patients were evaluated on days 1, 15 and 36 with the Brief Fatigue Inventory (BFI), Hospital Anxiety and Depression Scale (HADS), Quality of Life FACIT-F, FACIT-ES questionnaires, and Chalder Fatigue scale. Results: We enrolled 90 patients with a median age of 53 years (26 – 80). We saw no statistically significant differences of FACIT ES, FACIT F, HADS, Chalder or BFI scores treated with Catuama or Placebo when we considered all included patients. When we selected only patients with a BFI score above 30, Catuama significantly decreased BFI scores as compared to baseline (p<0.0001). We observed one instance of grade 3 hypermagnesemia in the Catuama arm and one patient had hyperglicemia grade 3 both in the Catuama and in the placebo arm. No grade 4 toxicities were seen. Conclusions: Catuama may help selected patients who already start RxT with evidence of fatigue.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Jasper应助sang采纳,获得10
刚刚
goovenph发布了新的文献求助10
1秒前
小胡发布了新的文献求助10
1秒前
xiaoxia完成签到,获得积分10
1秒前
bkagyin应助荼荼不是茶采纳,获得10
2秒前
烟花应助小于采纳,获得10
2秒前
3秒前
3秒前
灵主完成签到,获得积分20
5秒前
5秒前
dolabmu完成签到 ,获得积分10
5秒前
MOF@COF发布了新的文献求助10
6秒前
123完成签到,获得积分10
8秒前
现实的小蚂蚁完成签到 ,获得积分10
8秒前
9秒前
10秒前
L123发布了新的文献求助10
10秒前
123发布了新的文献求助10
10秒前
11秒前
l991215y完成签到,获得积分10
12秒前
可可爱爱没有脑袋完成签到,获得积分10
12秒前
大个应助灵主采纳,获得10
12秒前
knowledge159发布了新的文献求助10
13秒前
13秒前
14秒前
binsir发布了新的文献求助30
14秒前
童年的回忆klwqqt完成签到,获得积分10
16秒前
16秒前
科研通AI2S应助林子恒采纳,获得10
17秒前
xieenxe发布了新的文献求助10
17秒前
尊敬的半梅应助张龙雨采纳,获得10
18秒前
18秒前
慕青应助顺心冰海采纳,获得10
18秒前
jd发布了新的文献求助10
18秒前
MOF@COF发布了新的文献求助10
19秒前
斯文败类应助高高从筠采纳,获得10
20秒前
Zh发布了新的文献求助10
20秒前
充电宝应助jinman采纳,获得10
22秒前
大牛牛发布了新的文献求助10
22秒前
高分求助中
Evolution 3rd edition 1500
保险藏宝图 1000
Lire en communiste 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3182733
求助须知:如何正确求助?哪些是违规求助? 2832981
关于积分的说明 7991795
捐赠科研通 2495103
什么是DOI,文献DOI怎么找? 1331239
科研通“疑难数据库(出版商)”最低求助积分说明 636256
邀请新用户注册赠送积分活动 603313